141 related articles for article (PubMed ID: 38018231)
1. Primary cutaneous marginal zone lymphoproliferative disorder following COVID-19 vaccination.
Stephan C; Barone P; Kim J; Ma L
J Cutan Pathol; 2024 Mar; 51(3):193-197. PubMed ID: 38018231
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous lymphoproliferative disorders after COVID-19 vaccination: clinical presentation, histopathology, and outcomes.
Gordon ER; Kwinta BD; Schreidah CM; Fahmy LM; Adeuyan O; Queen D; Trager MH; Magro CM; Geskin LJ
Leuk Lymphoma; 2024 Jan; 65(1):48-54. PubMed ID: 37861685
[TBL] [Abstract][Full Text] [Related]
3. Primary Cutaneous Marginal Zone Lymphoproliferative Disorder of Donor Origin after Allogeneic Hematopoietic Stem Cell Transplantation.
Bejarano L; Sayagués JM; Alcoceba M; Balanzategui A; Lopez-Corral L; Cañueto J; Santos-Briz A
Am J Dermatopathol; 2023 Jun; 45(6):378-382. PubMed ID: 37130208
[TBL] [Abstract][Full Text] [Related]
4. The first autopsy case of Epstein-Barr virus-positive marginal zone lymphoma that deteriorated after COVID-19 vaccination.
Wang Z; Muto R; Miyoshi H; Aoki M; Uesugi N; Murayama H; Masutani K; Hamasaki M
Pathol Int; 2024 Feb; 74(2):87-92. PubMed ID: 38116849
[TBL] [Abstract][Full Text] [Related]
5. Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorder or Primary Cutaneous Marginal Zone B-Cell Lymphoma? Two Distinct Entities With Overlapping Histopathological Features.
Bakr F; Wain EM; Barlow R; Robson A
Am J Dermatopathol; 2021 Dec; 43(12):e204-e212. PubMed ID: 34231494
[TBL] [Abstract][Full Text] [Related]
6. Anetoderma arising in cutaneous B-cell lymphoproliferative disease.
Kasper RC; Wood GS; Nihal M; LeBoit PE
Am J Dermatopathol; 2001 Apr; 23(2):124-32. PubMed ID: 11285407
[TBL] [Abstract][Full Text] [Related]
7. Recurrence of primary cutaneous CD30-positive lymphoproliferative disorder following COVID-19 vaccination.
Brumfiel CM; Patel MH; DiCaudo DJ; Rosenthal AC; Pittelkow MR; Mangold AR
Leuk Lymphoma; 2021 Oct; 62(10):2554-2555. PubMed ID: 33974494
[No Abstract] [Full Text] [Related]
8. Hyperplasia of hair follicles and other adnexal structures in cutaneous lymphoproliferative disorders: a study of 53 cases, including so-called pseudolymphomatous folliculitis and overt lymphomas.
Kazakov DV; Belousova IE; Kacerovska D; Sima R; Vanecek T; Vazmitel M; Pizinger K; Michal M
Am J Surg Pathol; 2008 Oct; 32(10):1468-78. PubMed ID: 18685486
[TBL] [Abstract][Full Text] [Related]
9. Delayed Localized Hypersensitivity Reactions to the Moderna COVID-19 Vaccine: A Case Series.
Johnston MS; Galan A; Watsky KL; Little AJ
JAMA Dermatol; 2021 Jun; 157(6):716-720. PubMed ID: 33978670
[TBL] [Abstract][Full Text] [Related]
10. Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement.
Kazakov DV; Kutzner H; Palmedo G; Boudova L; Michaelis S; Michal M; Vanecek T; Magro CM; Mukensnabl P; Dummer R; Burg G; Kempf W
Am J Dermatopathol; 2006 Oct; 28(5):399-409. PubMed ID: 17012914
[TBL] [Abstract][Full Text] [Related]
11. Epidermotropic marginal zone lymphoma simulating mycosis fungoides(†).
Lee BA; Jacobson M; Seidel G
J Cutan Pathol; 2013 Jun; 40(6):569-72. PubMed ID: 23531038
[TBL] [Abstract][Full Text] [Related]
12. Primary cutaneous marginal zone B-cell lymphoma: a recently described entity of low-grade malignant cutaneous B-cell lymphoma.
Cerroni L; Signoretti S; Höfler G; Annessi G; Pütz B; Lackinger E; Metze D; Giannetti A; Kerl H
Am J Surg Pathol; 1997 Nov; 21(11):1307-15. PubMed ID: 9351568
[TBL] [Abstract][Full Text] [Related]
13. Primary Cutaneous CD4 Small/Medium T-Cell Lymphoproliferative Disorder Following COVID-19 Vaccination-What Do We Know about Lymphoproliferative Disorders and Cutaneous Lymphomas after COVID-19 Vaccination? A Report of an Atypical Case and a Review of the Literature.
De la Torre-Gomar FJ; Llamas-Molina JM; Pegalajar-García MD; Pérez-Valencia C; Carrero-Castaño A; Ruiz-Villaverde R
Life (Basel); 2024 Mar; 14(3):. PubMed ID: 38541710
[TBL] [Abstract][Full Text] [Related]
14. Overlapping Features of Primary Cutaneous Marginal Zone Lymphoproliferative Disorder and Primary Cutaneous CD4 + Small/Medium T-Cell Lymphoproliferative Disorder : A Diagnostic Challenge Examined by Genomic Analysis.
Obiorah IE; Karrs J; Brown L; Wang HW; Karai LJ; Pham TH; Pham TA; Xi L; Pittaluga S; Raffeld M; Jaffe ES
Am J Surg Pathol; 2023 Mar; 47(3):344-353. PubMed ID: 36598455
[TBL] [Abstract][Full Text] [Related]
15. Recurrent localized primary cutaneous marginal-zone B cell lymphoma.
Marmon S; Chu J; Patel R; Meehan S; Pomeranz MK
Dermatol Online J; 2011 Oct; 17(10):27. PubMed ID: 22031653
[TBL] [Abstract][Full Text] [Related]
16. A Rare Case of Monomorphic T-Cell Posttransplant Lymphoproliferative Disorder Presenting as Primary Cutaneous Anaplastic Large Cell Lymphoma, ALK Negative.
Robbins QC; Schmieg J; Rush WL; Allbritton JI
Am J Dermatopathol; 2022 Nov; 44(11):e124-e126. PubMed ID: 36066124
[TBL] [Abstract][Full Text] [Related]
17. Indurated Plaques on the Legs: Think Lymphoma.
Watts-Santos A; Cuellar-Barboza A; Ramos-Cavazos CJ; Villarreal-Martinez A; Ocampo-Candiani J; Herz-Ruelas ME
Acta Dermatovenerol Croat; 2021 Jul; 29(2):114-115. PubMed ID: 34477080
[TBL] [Abstract][Full Text] [Related]
18. The development of primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoproliferative disorder at the site of a melanoma excision scar.
Aria AB; Wilmas K; Kim EJ; Aung PP; Duvic M
Dermatol Online J; 2018 Sep; 24(9):. PubMed ID: 30677830
[TBL] [Abstract][Full Text] [Related]
19. Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder-clinical and histopathologic features, differential diagnosis, and treatment.
Gru AA; Wick MR; Eid M
Semin Cutan Med Surg; 2018 Mar; 37(1):39-48. PubMed ID: 29719019
[TBL] [Abstract][Full Text] [Related]
20. Primary cutaneous blastic marginal zone lymphoma: A comprehensive clinical, light microscopic, phenotypic and cytogenetic appraisal.
Magro CM; Kalomeris T; Roberts A
Ann Diagn Pathol; 2023 Apr; 63():152101. PubMed ID: 36634549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]